The president and top health officials acknowledged using the leverage of tariff threats to forge an agreement. Other companies are still in negotiations with the White House.The president and top health officials acknowledged using the leverage of tariff threats to forge an agreement. Other companies are still in negotiations with the White House. Prices (Fares, Fees and Rates), Drugs (Pharmaceuticals), United States Politics and Government, Health Insurance and Managed Care, Medicaid, Customs (Tariff), International Trade and World Market, United States International Relations, AstraZeneca PLC, Pfizer Inc, Trump, Donald J, Soriot, Pascal, Great Britain, European Union Read More
Trump Cuts a Deal With AstraZeneca to Lower Drug Prices
